Recent advances in engineering prodrug-based nanomedicines for cancer therapy

Shi, Linlin; Lin, Shanshan; Zhou, Fengping; Jiang, Hao; Zhang, Jin

doi:10.1039/d3ma01132a

Mater. Adv.

2024

DOI: 10.1039/d3ma01132a

|View full text |Cite

Recent advances in engineering prodrug-based nanomedicines for cancer therapy

Linlin Shi,

Shanshan Lin,

Fengping Zhou

et al.

Abstract: Despite substantial progress, nanomedicines still face numerous obstacles in cancer therapy. The marriage of prodrugs and nanoparticles cooperatively offers several benefits as a potent platform for valid anticancer drug delivery,...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

2025

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 164 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

pH/ROS co-triggered degradable polyprodrug as self-amplified drug self-delivery system for tumor-specific doxorubicin delivery

Zhao,

Liu

2025

Colloids and Surfaces A: Physicochemical and Engineering Aspect

View full text Add to dashboard Cite

pH/ROS co-triggered degradable polyprodrug as self-amplified drug self-delivery system for tumor-specific doxorubicin delivery

Zhao,

Liu

2025

Colloids and Surfaces A: Physicochemical and Engineering Aspect

View full text Add to dashboard Cite

Anionic polysaccharides as delivery carriers for cancer therapy and theranostics: An overview of significance

Sivakumar,

Zarepour,

Akther

et al. 2024

International Journal of Biological Macromolecules

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Recent advances in engineering prodrug-based nanomedicines for cancer therapy

Abstract: Despite substantial progress, nanomedicines still face numerous obstacles in cancer therapy. The marriage of prodrugs and nanoparticles cooperatively offers several benefits as a potent platform for valid anticancer drug delivery,...

Cited by 2 publications

References 164 publications

pH/ROS co-triggered degradable polyprodrug as self-amplified drug self-delivery system for tumor-specific doxorubicin delivery

pH/ROS co-triggered degradable polyprodrug as self-amplified drug self-delivery system for tumor-specific doxorubicin delivery

Anionic polysaccharides as delivery carriers for cancer therapy and theranostics: An overview of significance

Contact Info

Product

Resources

About